Loredana Bălăcescu, PhD student

Speciality: physics, bioinformatics, biostatistics
Present positions: physicist
Scientific title: PhD student in Biology
Babeş-Bolyai University, Diploma in Physics
Studies: Technical University of Cluj-Napoca, Postuniversitary degree in informatics and computer programming
Profesional experience: Microarray data analysis (gene expression) in prostate, breast and ovarian cancer. Biostatistics evaluation of serum protein levels using FastQuant Array in tumor angiogenesis study.
Specialisations and qualifications :
2006 Functional Genomics in Cancer Biology and Therapy, summer school, Cluj-Napoca, Romania

2007 A Joint EMBL/Agilent Technologies Practical Course on MicroRNA Profiling, EMBL Heidelberg, Germany

2008 OECI Pathobiology Workshop „Structure and Genetics, the new Paradigm”, Cluj-Napoca, Romania

2008 International Workshop „Principles and Applications of Functional Genomics in Cancer Biology and Therapy”, Cluj-Napoca, Romania
National/international programmes:
CEEX - Micro and tissue array in epithelial ovarian tumor molecular signature with low and high malignancy potential. Candidate genes in borderline tumor angiogenesis – MT-ARRAY-SIGN. Member 2006-2008

CEEX - Comparative analysis of molecular profile in cystic lesions of pancreas. Microarray technique used to evaluate the gene expression level – PANARRAY. Member 2006-2008
CEEX – Development of a system biology approach for understanding he molecular and signaling patterns involved in the human prostate - MOLPAT. Member 2006-2008

CNMP (PNCDI II) - Transcriptomic molecular profile definition in prediction of clinical status in breast cancers resistant to anthracyclines. Metastatic disease definition in relation to primary tumor - BREAST-OMICS. Member 2007-2010

CNMP (PNCDI II) Improvement of early diagnosis and treatment of biliary ducts malignant stenosis using miniprobe intraductal ultrasound, microarray techniques and neoadjuvant photodynamic therapy - LASENDO. Member 2007-2010

CNMP (PNCDI II) Minimal invasive therapy implementation in colorectal cancer; improvement of diagnosis and prognosis in correlation with plasmatic levels of angiogenesis molecules related to VEGF – CELIOMARK. Member 2007-2010
CNMP (PNCD II) - The identification of the transcriptomic molecular profiles in advanced stage cervical cancer using functional genomic studies. CERVIX-ARRAY. Member 2008-2011

CNCSIS ( IDEAS )- In vitro identification of predictive molecular markers in response to treatment with oxaliplatin in colorectal cancers. Their use in vivo models in translational research. Member 2008-2011